OBJECTIVES/HYPOTHESIS: To compare three different inoculation techniques for the development of cytomegalovirus (CMV)-induced sensorineural hearing loss (SNHL) in a mouse model. STUDY DESIGN: A prospective experimental animal study. METHODS: BALB/c mice underwent inoculation using green fluorescent protein-expressing mouse cytomegalovirus (mCMV-GFP) via transtympanic (TT), intraperitoneal (IP), or intracranial (IC) routes. Control mice received an equal volume of saline. Hearing thresholds were measured using both distortion product otoacoustic emissions (DPOAE) and evoked auditory brainstem response studies (ABR). Cochleas were harvested for histological examination and cytocochleogram. RESULTS: No mice in the TT or IP groups showed significant hearing loss. All infected mice in the IC group showed significantly elevated ABR and DPOAE thresholds at 4 weeks of age. Ten mice (55%) had profound hearing loss (≥80 dB) at 4 weeks of age, while the other eight mice (45%) initially showed moderate hearing loss (≤20 dB), which progressed to profound hearing loss by 6 to 8 weeks. Asymmetric hearing loss was seen in 40% of the mice. Temporal bone histology showed diffuse loss of outer hair cells (OHC). Green fluorescent protein (GFP)-labeled virus was abundant in the spiral ganglion and adjacent to the scala tympani at the basal region of the cochlea at 7 days postinjection, and devoid of GFP labeling by 14 days postinfection. CONCLUSIONS: Intracerebral injection of mCMV preferentially causes mCMV-mediated hearing loss relative to IP or TT injections. These results are consistent with the hearing loss reported in human congenital infection and may have implications for understanding the pathophysiology of CMV-mediated labyrinthitis.
OBJECTIVES/HYPOTHESIS: To compare three different inoculation techniques for the development of cytomegalovirus (CMV)-induced sensorineural hearing loss (SNHL) in a mouse model. STUDY DESIGN: A prospective experimental animal study. METHODS: BALB/c mice underwent inoculation using green fluorescent protein-expressing mouse cytomegalovirus (mCMV-GFP) via transtympanic (TT), intraperitoneal (IP), or intracranial (IC) routes. Control mice received an equal volume of saline. Hearing thresholds were measured using both distortion product otoacoustic emissions (DPOAE) and evoked auditory brainstem response studies (ABR). Cochleas were harvested for histological examination and cytocochleogram. RESULTS: No mice in the TT or IP groups showed significant hearing loss. All infected mice in the IC group showed significantly elevated ABR and DPOAE thresholds at 4 weeks of age. Ten mice (55%) had profound hearing loss (≥80 dB) at 4 weeks of age, while the other eight mice (45%) initially showed moderate hearing loss (≤20 dB), which progressed to profound hearing loss by 6 to 8 weeks. Asymmetric hearing loss was seen in 40% of the mice. Temporal bone histology showed diffuse loss of outer hair cells (OHC). Green fluorescent protein (GFP)-labeled virus was abundant in the spiral ganglion and adjacent to the scala tympani at the basal region of the cochlea at 7 days postinjection, and devoid of GFP labeling by 14 days postinfection. CONCLUSIONS: Intracerebral injection of mCMV preferentially causes mCMV-mediated hearing loss relative to IP or TT injections. These results are consistent with the hearing loss reported in human congenital infection and may have implications for understanding the pathophysiology of CMV-mediated labyrinthitis.
Authors: Amnon A Berger; Yaniv Gil; Amos Panet; Yiska Weisblum; Esther Oiknine-Djian; Michal Gropp; Debora Steiner; Benjamin E Reubinoff; Dana G Wolf Journal: J Virol Date: 2015-08-19 Impact factor: 5.103
Authors: Vladimir Tsuprun; Nevra Keskin; Mark R Schleiss; Pat Schachern; Sebahattin Cureoglu Journal: Am J Otolaryngol Date: 2019-08-02 Impact factor: 1.808
Authors: Ali Almishaal; Pranav Dinesh Mathur; Lesley Franklin; Kevin Shi; Travis Haller; Aleksandra Martinovic; Kayla Hirschmugl; Brian R Earl; Chong Zhang; Jun Yang; Michael R Deans; Matthew A Firpo; Albert H Park Journal: Int J Pediatr Otorhinolaryngol Date: 2020-08-04 Impact factor: 1.675
Authors: Phayvanh P Pecha; Ali A Almishaal; Pranav D Mathur; Elaine Hillas; Taelor Johnson; Melissa S Price; Travis Haller; Jun Yang; Namakkal S Rajasekaran; Matthew A Firpo; Albert H Park Journal: Otolaryngol Head Neck Surg Date: 2020-02-11 Impact factor: 5.591
Authors: Ali A Almishaal; Pranav D Mathur; Elaine Hillas; Liting Chen; Anne Zhang; Jun Yang; Yong Wang; Wayne M Yokoyama; Matthew A Firpo; Albert H Park Journal: PLoS Pathog Date: 2017-08-31 Impact factor: 6.823